Legend Biotech Corporation
Legend Biotech Corporation (LEGN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · LEGN · as of Sep 30, 2025
Ownership Breakdown
216
Institutional Holders
▼ 10 vs Q2
$2.73B
Total Inst. Value
▼ $274.43M vs Q2
184.94M
Shares Outstanding
freeFloat 96.34%
83.70M
13F Shares Held
▼ 938,132 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
LEGN largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
FMR LLC pharmaceutical preparations | 27.70M | 30.09% | 30.09% | $903.39B | Nov 13, 2025 | ▲ 2.03M |
WESTFIELD CAPITAL MANAGEMENT CO LP pharmaceutical preparations | 6.09M | 6.62% | 6.62% | $198.74B | Nov 12, 2025 | ▼ 378.1K |
HHLR ADVISORS, LTD. pharmaceutical preparations | 5.98M | 6.50% | 6.50% | $195.16B | Nov 14, 2025 | — held |
BLACKROCK, INC. pharmaceutical preparations | 4.49M | 4.88% | 4.88% | $146.57B | Nov 12, 2025 | ▲ 246.1K |
SUVRETTA CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 3.82M | 4.15% | 4.15% | $124.51B | Nov 14, 2025 | ▲ 44.0K |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) pharmaceutical preparations | 2.96M | 3.22% | 3.22% | $96.60B | Nov 14, 2025 | — held |
ARTISAN PARTNERS LIMITED PARTNERSHIP pharmaceutical preparations | 2.55M | 2.77% | 2.77% | $83.09B | Nov 12, 2025 | ▲ 425.7K |
JANUS HENDERSON GROUP PLC pharmaceutical preparations | 2.13M | 2.31% | 2.31% | $69.29B | Nov 14, 2025 | ▲ 32.4K |
BRAIDWELL LP pharmaceutical preparations | 1.83M | 1.98% | 1.98% | $59.55B | Nov 14, 2025 | ▼ 715.9K |
ALLIANCEBERNSTEIN L.P. pharmaceutical preparations | 1.63M | 1.77% | 1.77% | $53.25B | Nov 14, 2025 | ▲ 72.4K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
31
Increased
+4.79M shares1
New Positions
first time holders12
Decreased
−1.77M shares0
Sold Out
fully exitedNet shares change (top 50)
+3.02M
+4.79M / −1.77M
Net new holders
+20
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
LEGN insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
1
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Huang Ying Chief Executive Officer | Mar 25, 2026 | Sale | 9,936 | $8.77 | $87.1K | 247.4K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Legend Biotech Corporation (LEGN) is primarily owned by institutional investors, who hold approximately 45.3% of total shares outstanding. Company insiders own approximately 3.66%, while retail and public investors account for the remaining 51.09%.
The largest institutional shareholder of Legend Biotech Corporation is FMR LLC, holding approximately 27.70 million shares — equal to 30.09% of outstanding shares — as of September 30, 2025.
A total of 216 institutional investors currently hold LEGN stock, with a combined institutional value of approximately $2.73 billion as of the most recent 13F filing period.
Frequently asked questions
LEGN ownershipLegend Biotech Corporation (LEGN) is primarily owned by institutional investors, who hold approximately 45.3% of shares. The largest shareholder is FMR LLC with a 30.09% stake. Company insiders hold 3.66%. Data sourced from SEC Form 13F as of September 30, 2025.